For Health Care Professionals: Preparing Your Practice/Fight Flu Toolkit

As healthcare professionals prepare to have conversations with patients around flu vaccination, CDC has pulled together a suite of digital and print-off materials to help in effectively conveying the threat of flu and why flu vaccination is so important. 

These resources include:

For the General Public/Patients: CDC Digital Media Toolkit

We have updated this webpage and related social media images and messages to reflect the upcoming flu season. 

#WhyIFightFlu

CDC is currently collecting a variety of Flu Fighter profiles through partners, describing how members of the American public have been affected by flu and why they fight the often devastating disease. We are aiming to post these profiles after the annual flu vaccination season kickoff press conference hosted by NFID on 9/26.

This hashtag campaign is focused on reinforcing the negative impact of flu and positive benefits of flu vaccine. In that vein, we are inviting all of our partners to use the hashtag #WhyIFightFlu and share an answer to the question "why do you fight flu?" as we move forward with flu season.

ADDITIONAL RESOURCES

SAVE THE DATE

  • August 28, 2019: To conclude National Immunization Awareness Month (NIAM), CDC is hosting a webinar on 8/28 focused on addressing vaccine hesitancy in the practice. This will not be flu-specific, but will have some overarching strategies on addressing vaccine misinformation. More information and registration here.
  • September 26, 2019: Watch and promote the livestream of the annual flu vaccination season kickoff press conference hosted by the National Foundation for Infectious Diseases (NFID). Link will be shared closer to the kickoff.
  • December 1-7, 2019: Join CDC in promoting flu vaccination before and during National Influenza Vaccination Week (NIVW). NIVW-specific updates, events, and resources will be posted on CDC's NIVW website.
  • TBD: Webinar focused on talking through the many different flu vaccines for the 2019-20 flu season and making a strong flu vaccine recommendation – tentatively set for early October; more details coming soon
  • Throughout flu season: We will be sharing stories of why members of the American public fight flu with the hashtag #WhyIFightFlu

The CDC released results from the National Immunization Survey-Teen (NIS-Teen) in the Morbidity and Mortality Weekly Report, which provides the latest estimates of vaccination rates among adolescents in the United States.

The key findings from the report include:

  • HPV vaccination rates increased slightly, but there was no increase in rates among girls, highlighting the need for continued efforts to ensure all boys and girls are vaccinated on time.
  • Vaccination rates are lower in rural areas, and differ by insurance status.
  • This report reinforces the important role that healthcare professionals can play in increasing vaccination rates and addressing disparities.

Based on the findings, everyone has a role to play in improving vaccination rates. CDC is emphasizing the following calls to action:

Call to Action: Public health programs should work with doctors and their practices to develop better tools to meet the needs of parents to encourage vaccine acceptance. 

  • Parents
    • Ask your child’s doctor about the HPV vaccine when they are 11 or 12 years old.
  • Immunization Programs and Partners
    • Share resources with healthcare professionals to support them in making effective vaccine recommendations and addressing parents’ questions.
    • Partner with organizations focused on rural health to disseminate resources to healthcare professionals in rural areas.
    • Remind parents about the vaccines that are recommended for their child before the start of the school year.

This week’s MMWR also included a report on the latest estimates of HPV cancers in the United States, which found that HPV vaccination could prevent 92% of cancers estimated to be caused by HPV.

To support healthcare professionals in making effective recommendations, addressing parents’ questions and concerns, and reinforce the message that HPV vaccination is cancer prevention, CDC has developed a number of educational resources, which can be found here. Below are a few specific resources we’d like to highlight to assist you in your efforts to reach healthcare professionals and parents.

Resources for Healthcare Professionals

Resources for Parents

Last week, CDC published updated recommendations for HPV vaccination of adults in the MMWR: https://www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm. CDC has updated its web content to reflect the latest recommendations among adults, including developing a new HPV Vaccine Schedules and Dosing page for healthcare professionals to outline HPV vaccine recommendations and guidance for how to talk with parents and patients about vaccine recommendations.

Finally, we encourage you to attend, and inform your members about, next week’s webinar on Strategies for Addressing Vaccine Misinformation in the Practice Setting.

August 21, 2019

 

Customs and Border Patrol’s Flu Vaccine Policy Breaches Basic Public Health Tenet

 

Statement from IDSA President Cynthia Sears, MD, FIDSA, HIVMA Chair W. David Hardy, MD, SHEA President Hilary Babcock, MD, MPH, FIDSA, FSHEA, PIDS President Paul Spearman, MD, FPIDS, and ASTMH President Chandy C. John, MD, MS:

The U.S. Customs and Border Patrol’s decision to withhold vaccinations against seasonal influenza from migrants in border detention facilities is a violation of the most basic principles of public health and human rights. It runs directly counter to the imperative that no individual should be harmed as a result of being detained, and that the community standard of medical care be available to persons in the custody of the U.S. government.

An essential tool in protecting both individual and public health, vaccinations against potentially life-threatening and preventable illnesses are an indispensable component of routine healthcare. Since 2010, the U.S. Centers for Disease Control and Prevention has recommended annual influenza vaccination for ALL persons 6 months of age or older in the absence of medical reasons not to be vaccinated, a recommendation that, as organizations of more 16,000 infectious diseases specialists, we stand firmly behind. According to the CDC, seasonal influenza was associated with over 57,000 deaths – 129 in children—during the recent 2018-2019 season. In conditions of overcrowding poor sanitation and emotional stress involving vulnerable populations such as pregnant women and young children, choosing not to follow the CDC recommendations is particularly egregious.

The Infectious Diseases Society of America, the HIV Medicine Association, the Pediatric Infectious Diseases Society, the Society for Healthcare Epidemiology of America, and the American Society of Tropical Medicine and Hygiene call for the immediate articulation and implementation of a plan to administer vaccinations against seasonal influenza and to ensure the delivery of all other routine medical immunizations in facilities under the oversight of U.S. Customs and Border Patrol. We remain deeply concerned about the treatment of immigrants at our borders and in federal detention, and we call for a comprehensive investigation of the agency’s protocol for providing health care at its facilities.

###

Contact

IDSA: Jennifer Morales 
This email address is being protected from spambots. You need JavaScript enabled to view it. 
(703) 299-0412

PCI: Lauren Martin
(312) 558-1770 
This email address is being protected from spambots. You need JavaScript enabled to view it.

View Press Release PDF copy

Statement from IDSA President Cynthia Sears, MD, FIDSA, HIVMA Chair W. David Hardy, MD, SHEA President Hilary Babcock, MD, MPH, FIDSA, FSHEA, and PIDS President Paul Spearman, MD, FPIDS:

 

Press Release

______________________________________________________________________________________

Embargoed 1 PM ET                                                                                         Contact: CDC Media Relations

July 9, 2019                                                    July 9, 2019                                                                                                                                (404) 639-3286

 

CDC Urges Doctors to Rapidly Recognize and Report AFM Cases

Intense effort underway to understand and prevent this serious neurologic syndrome

As the late summer/early fall “season” for acute flaccid myelitis (AFM) nears, CDC is calling on medical professionals to quickly recognize AFM symptoms and report all suspected cases to their health department. Early recognition and reporting are critical for providing patients with appropriate care and rehabilitation, and better understanding AFM, according to a new Vital Signs report.

The majority of AFM patients are previously healthy children who had respiratory symptoms or fever consistent with a viral infection less than a week before they experienced limb weakness. Since AFM can progress quickly from limb weakness to respiratory failure requiring urgent medical intervention, rapidly identifying symptoms and hospitalizing patients are important.

Dr. Robert Redfield, CDC Director

_______________________________________________________

“Timing is key for responding to AFM and outbreaks. The quicker doctors recognize symptoms, collect specimens, and report suspected cases to health departments, the more insight we gain into this serious illness,” said CDC Director Robert Redfield, M.D. “AFM is a national public health priority. CDC is working with the AFM Task Force to strengthen the knowledge base about how viruses cause AFM, and best practices around patient treatment and rehabilitation.”

__________________________________________________________________________________________

Late summer and early fall is AFM “season”

CDC began tracking AFM in 2014, when the first outbreak of 120 cases occurred. Another outbreak occurred in 2016 with 149 cases, and again with 233 patients in 41 states in 2018– the largest outbreak so far. AFM cases have so far followed a seasonal and biennial pattern, spiking between August and October every other year.

In an analysis of cases confirmed in 2018, CDC detected enteroviruses and rhinoviruses in nearly half of respiratory and stool specimens. Of the 74 cases with a cerebral spinal fluid specimen, only two were positive for enteroviruses (EV-A71 and EV-D68). CDC and other scientists continue to investigate how enteroviruses, including EV-D68, might initiate AFM. All specimens tested negative for poliovirus, a related enterovirus that can cause AFM. 

Dr. Tom Clark, deputy director, Division of Viral Diseases

____________________________________

“Our thorough investigation of AFM will help lead to more answers about this severe disease,” said Tom Clark, M.D., M.P.H, deputy director, Division of Viral Diseases. “We are monitoring AFM trends and the clinical presentation, conducting research to identify possible risk factors, using advanced lab testing and research to understand how viral infections may lead to AFM, and tracking long-term outcomes of AFM patients.”

_________________________________________________________________________________________  

CDC, with experts from the National Institutes of Health, academia, health departments, and parent advocacy groups, is committed to increasing awareness of AFM, and moving national priorities forward to advance our understanding of AFM and its prevention, treatment, and outcomes.

To read more about the Nationwide Outbreak of Acute Flaccid Myelitis—United States, 2018 and the entire Vital Signs report, visit www.cdc.gov/vitalsigns.

About Vital Signs

Vital Signs is a report that appears as part of the CDC’s Morbidity and Mortality Weekly Report. Vital Signs provides the latest data and information on key health indicators.

 

###

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

 

 

 

//IDSA / HIVMA /PIDS logos//

NEWS RELEASE
June 24, 2019

Physicians, Health Providers and Researchers Call on Presidential Candidates to Back Funding, Preparedness and Evidence-based Responses to Infectious Diseases, HIV

Contact IDSA: Jennifer Morales This email address is being protected from spambots. You need JavaScript enabled to view it. (703) 299-0412 PCI Public Relations (312) 558-1770  This email address is being protected from spambots. You need JavaScript enabled to view it.

In a bipartisan-aimed petition, more than 500 members of the Infectious Diseases Society of America, its HIV Medicine Association and the Pediatric Infectious Diseases Society are calling on all presidential candidates to commit themselves to public health policies, programs, and investments necessary to protect the lives and health of Americans and reduce the impact of infectious diseases globally, including from the threats of growing and emerging infectious diseases, vaccine preventable diseases, infections increasingly resistant to existing treatments, as well as from the impacts of climate change.

Urging strong stances, support and funding for public health measures against leading domestic and global health challenges, the signers urge White House aspirants to articulate their priorities for tackling infectious diseases opportunities and threats, including with interventions to:

  • Increase vaccine access and uptake;
  • Strengthen responses to the opioid crisis and associated infectious disease impacts;
  • Build antibiotic stewardship, research and development;
  • Sustain U.S. leadership of global HIV and TB responses, while enhancing global health security efforts;
  • Expand interventions to reverse increased rates of sexually transmitted diseases;
  • Use existing tools to end the HIV epidemic and eliminate hepatitis C virus in America;
  • Confront climate change;
  • And build the infectious diseases and HIV trained health workforce necessary to meet these challenges.

The full petition, with further information on infectious diseases priorities and actions, is here.

###


11th Annual International Pediatric Antimicrobial Stewardship Conference - June 4-5, 2020

 

To Register, visit:  https://sites.wustl.edu/pasc/

This course is designed for pediatricians, general practitioners, family practitioners, infectious disease and critical care specialists to improve antimicrobial prescribing for all children. This will be accomplished by increasing the knowledge and competence of individuals beginning an antimicrobial stewardship program. Additionally, the course is designed to improve the performance of current antimicrobial stewardship programs.  At the conclusion of this activity attendees should be able to:

  • List the antimicrobial stewardship strategies utilized to improve antimicrobial prescribing in all healthcare settings.
  • Discuss the important communication techniques to improve antimicrobial prescribing in all healthcare settings.
  • Describe the current rates of antimicrobial resistance and adverse drug reactions in children.

 

This activity has been planned and implemented by the Pediatric Infectious Diseases Society (PIDS), Society of Infectious Diseases Pharmacists (SIDP), and Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

American Medical Association (AMA)
Washington University School of Medicine in St. Louis designates this live activity for a maximum of 12.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC)
Washington University School of Medicine in St. Louis designates this live activity for a maximum of 12.00 contact hours.

Accreditation Council for Pharmacy Education (ACPE)
This activity is approved for 12.25 contact hours (1.225 CEUs) in states that recognize ACPE. Attending the full program will earn 12.25 contact hours (1.225 CEUs), UAN –#. To be awarded credit, attendees must have participated in all sessions, complete the activity evaluation, and provide your NABP ePID number and date of birth.

Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 12.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

**************************************************

Record Number of Abstracts Submitted to 2019 Antimicrobial Stewardship Conference - St. Louis, MO

During this year's Antimicrobial Sterwardship Conference, We had a record number of participants (220) and abstracts (77) this year. Leading experts from around the country discussed important antimicrobial stewardship topics including Gram-negative resistance (Latania Logan MD), stewardship for the pediatric intensive care unit (Kathleen Chiotos MD) and communication insights for stewards (Julia Szymczak, PhD). The three Pediatric ID ASP Fellow award winners (Rebecca Same, MD, Sophie Katz, MD and Maria Equiguren Jimenez, MD) presented their outstanding research.   Two ASP conference attendees had the following to say about the 2019 conference:

"This was my first time attending this conference.  I absolutely loved it. It was for two days so not too long. Lectures were all pediatric relevant and in line with ASP priorities.  Networking with colleagues in other places is invaluable. Will surely go back next year!"  ~ Dr. Upadhyayula
 
"The PIDS ASP conference was a fantastic opportunity to talk to other stewards about their programs and research and discuss some of the obstacles that we face at my home institution. I came away from the conference with multiple ideas for our program from small tweaks to larger policy goals." ~ Dr. TeKippe
 

 

   
 

Please be aware that www.idweek.org is the only official site for registering for IDWeek 2019. Experient is the official housing provider for IDWeek 2019 and their site can only be accessed through www.idweek.org. International groups can also use www.idweekinternational.com for housing and travel assistance.

Fraudulent websites have been reported, so it is critical that you use only the official IDWeek websites mentioned above to register for the meeting and for booking a hotel reservation through IDWeek. We do not ask for member identification numbers during registration, and no one will email you to ask for your membership password. Please do not provide this information if requested, and be aware that you are using an illegitimate website.

IDWeek cannot guarantee your registration or housing if you purchase using an illegitimate website.
 

IDWeek staff make every effort to shut down illegitimate websites as soon as we are made aware of them; however, new attempts to create fraudulent sites occur regularly. If you are concerned about your registration, please contact IDWeek staff at This email address is being protected from spambots. You need JavaScript enabled to view it..

Dear Colleagues:

 

We are in the midst of an upsurge in measles in the US, thanks largely to the dedicated misinformation efforts of the anti-vaccine movement. I wonder if we could learn from the history of polio vaccination as we try to fight the rise in vaccine hesitancy in this country. A little local history from here in Cincinnati might help. On April 24, 1960, Albert Sabin participated in the initial rollout of the oral polio vaccine he had developed at Cincinnati Children’s Hospital on the first “Sabin Sunday.” He was surprised at the huge lines of parents bringing their children in for his vaccine, and by the end of the day more than 20,000 local children had received the vaccine. Vaccine uptake eventually became so universal that polio was eradicated from the Western hemisphere and from most of the world. What is different now? I think one major factor is that severe disease from measles does not seem real to most Americans, and very few have seen it affect themselves or their neighbors. In the case of polio, there was great fear of the crippling effects that could result from the infection, and this fear plus perhaps a healthy respect for science led to enthusiastic vaccine uptake. It seems that right now our communities could use a healthy dose of fear of the infectious diseases that our vaccines can now prevent, along with real education about vaccine safety to counteract misinformation from the anti-vaxxers. One of our key missions at PIDS is to promote vaccine uptake in order to save the lives of children, and as a society we stand firmly against non-medical vaccine exemptions. Let’s help think of ways to also educate our communities about the seriousness of vaccine-preventable diseases, as we seek always to build trust in the safety and efficacy of vaccines.

 

Peace,     

Dr. Paul Spearman

PIDS Board President

Dear Provider,

Due to the current increase in measles cases in the United States (https://www.cdc.gov/mmwr/volumes/68/wr/mm6817e1.htm), the Centers for Disease Control and Prevention has developed the following summary for vaccination of adults against measles with measles, mumps, rubella (MMR) vaccine. Recommendations for vaccination and assessing immunity in adults have not changed since publication of the Advisory Committee on Immunization Practices (ACIP) recommendations for the Prevention of Measles, Rubella, Congenital Rubella syndrome, and Mumps in June 2013. (https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6204a1.htm)

WHAT ADULT PROVIDERS NEED TO KNOW:

Providers do not need to actively screen adult patients for measles immunity.  This is because of high population immunity and low risk of disease among adults in non-outbreak areas in the U.S.

Providers should make sure patients have measles protection before international travel.  U.S. residents traveling internationally are at high risk for acquiring measles abroad.  They can also transmit measles to susceptible persons, such as infants, when they return home.

If a patient is traveling internationally and measles immunity is unknown, providers should vaccinate, unless there are contraindications.  Serologic testing for measles immunity is not recommended.

During outbreaks, providers should consult with local health departments for the most up-to-date recommendations for their community.  This may include additional doses of MMR for your patients.  

To download and print this letter in its entirety, click here.

            The Social Media Working Group is an ad hoc taskforce working under the auspices of the Communications Committee, focused on delivering a vibrant, engaging, and educational presence for PIDS on a variety of social media. The goals of our group are to help develop a cohesive and impactful communications portfolio, and then deliver this messaging to our membership, as well as non-member interested parties and international colleagues, through Twitter, Facebook, and LinkedIn.

            Most members who are “Twitter-active” will have likely seen our work on our Twitter feed, which is our most active social media account, and where we receive the most traffic. However, we also encourage you to look into our Facebook page, where we post live feeds from conferences, including most recently the St Jude/PIDS conference in Memphis, as well as our LinkedIn account.

            We seek to keep our membership and the broader community apprised of important awareness events, such as World Immunization Week, World AIDS Day, and others, as well as new and interesting news and journal articles in pediatric infectious diseases. We also seek to advocate for core PIDS priorities, in particular vaccines and health promotion. We work closely with our colleagues at the social media accounts of the Journal of the Pediatric Infectious Diseases Society (JPIDS), our society’s flagship publication.

            In the coming months, look out for some planned “tweet-storms” around important events, in particular ID Week in October, as well as some Twitter and Facebook Q&A “Meet the Professor” sessions. If you have an interest in all of this, and would like to impact the work that PIDS does on advocating on #SoMe (social media!), please reach out to any member of our working group. We are always looking for new and enthusiastic members!

For the Social Media Working Group (SMWG) –

Kevin O’Callaghan (Social Media Editor – PIDS)

Saul Hymes (JPIDS Social Media Editor)

JB Cantey

Michael Chang

Ozlem Equils

Christina Gagliardo

Rana Hamdy

Claudette Poole

Caroline Reuter

Diana Yu

Want to stay up to date with hot topics published in Pediatric Infectious Diseases?

The Australasian Society for Infectious Diseases (ANZPID) has an open-access Journal Club and Quiz Club that posts monthly. Articles of interest are appraised by ANZPID members, as well as members of other international Pediatric Infectious Diseases societies, including PIDS. The focus of this Journal Club is to highlight practice-changing literature in our field. At the end of each appraisal, there is brief Q&A relating to the article's findings. This is an excellent educational resource from trainees to faculty! PIDS contributes to this Journal Club twice a year. This is a great opportunity particularly for trainees, as the appraisal can be considered for a "Heads Up" publication in the Journal of Paediatric and Child Health journal. The link to the ANZPID journal club site is: https://www.asid.net.au/groups/paediatric-id-journal-and-quiz-club  From here you can navigate to 2019, or back through prior years.

If you have any questions or are interested in submitting an appraisal on behalf of PIDS, please contact Rosey Olivero at This email address is being protected from spambots. You need JavaScript enabled to view it..

National Infant Immunization Week (NIIW) is an annual observance to highlight the importance of protecting infants from vaccine-preventable diseases and to celebrate the achievements of immunization programs in promoting healthy communities throughout the United States. This year, NIIW will be April 27-May 4, 2019.

  • In 2019, we are celebrating the 25th anniversary of NIIW. When the NIIW observance was established in 1994, immunization programs were facing significant challenges. The nation was in the midst of a serious measles outbreak and communities across the U.S. were seeing decreasing immunization rates among children.

Vaccines are among the most successful and cost-effective public health tools available for preventing disease and death. They not only help protect vaccinated individuals, but also help protect entire communities by preventing and reducing the spread of infectious diseases. Among children born during 1994-2018, vaccination will prevent an estimated 419 million illnesses, 26.8 million hospitalizations, and 936,000 deaths over the course of their lifetimes.

NIIW provided an opportunity to draw attention to these issues and to focus on solutions. Communities have continued to use the week each year to raise awareness about the importance of ensuring all children are fully protected from vaccine preventable diseases through vaccination. Today, many immunization programs, partners and communities can celebrate high infant vaccination rates.

For more information on NIIW, please visit:  www.cdc.gov/vaccines/niiw

By Janet R. Gilsdorf, MD, Chair

The PIDS Nominations and Awards Committee is seeking nominees for President-Elect, Secretary-Treasurer, two (2) Directors, and three (3) members for the Nominations and Awards Committee. In order to recruit the most qualified individuals to serve, the committee needs your input. Members of the Society may self-nominate or identify a colleague who is willing to be considered for nomination. Below are the desired leadership qualifications and the commitment of time necessary for each position.
 
Qualifications:

  • Demonstrated commitment to PIDS (e.g., committee work) and the pediatric infectious diseases community
  • Interest in shaping PIDS’ direction, philosophy and policies
  • Strong background in committee and volunteer work
  • Effective skills in communication, listening, organization, and planning
  • Ability to identify and solve problems
  • Willingness to express or entertain diverse perspectives
  • Respect and recognition by peers in the infectious diseases community
  • Willingness to commit the time required to actively participate in PIDS activities

President-Elect (two-year term):

The President-Elect attends two Board meetings per year (held in conjunction with the PIDS/St. Jude Meeting and IDWeek); serves as a member of the Executive Committee and participates on quarterly conference calls; participates in strategic planning for the Society; and performs the duties and powers of the President in his/her absence or in the event of death, or inability to act. The President-Elect also serves as the vice chair of the PIDS Foundation.

Secretary-Treasurer (two-year term):

The Secretary-Treasurer attends two Board meetings per year (held in conjunction with the PIDS/St. Jude Meeting and IDWeek); serves as a member of the Executive Committee and participates on quarterly conference calls; participates in strategic planning for the Society; anticipates and brings to the Board of Directors potential changes in operation, finance, governance, committee structure and bylaws that would better serve the Society's goals; and performs the duties and powers of the President and President-Elect in their absence or in the event of death or inability to act until Board arranges an election to fill the vacancy.

PIDS Board of Directors Member-At-Large: (four-year term). A Member-At-Large attends two Board meetings per year (held in conjunction with the PIDS/St. Jude Meeting and IDWeek); participates in strategic planning for the Society; participates in ad hoc conference calls and votes; anticipates assuming chairmanship and/or membership of one or more PIDS committees.
 
Nominations Committee Member: (two-year term). Committee member participates in two-three conference calls a year to select a slate for that year’s officers, directors, Nominations and Awards Committee, and awards; participates in invigorating the process of recognition of colleagues; helps write biographical sketches of awardees for announcement and publication.
 
Click here to submit a nomination. The deadline to submit nominations is Wednesday, May 29th. Once you have submitted your nomination, please forward a brief biographical sketch or curriculum vitae and a statement outlining prior participation in PIDS activities to Christy Phillips via e-mail (This email address is being protected from spambots. You need JavaScript enabled to view it.).

Innovative Tool Offers Expert Guidance to Help Prevent Infections in Children

A new comprehensive resource provides practical, expert guidance for the urgent fight against healthcare-associated infections in children across a wide range of medical settings. Available to pre-order now, the Handbook of Pediatric Infection Prevention and Control fills an important gap in the healthcare field by addressing the nuances and challenges specific to preventing infections in children, from the clinic to the intensive care unit and beyond.

“Children are not just tiny adults, and this impacts many aspects of their medical care, including infection prevention,” said handbook co-editor Kristina A. Bryant, MD, professor of pediatrics in the Division of Pediatric Infectious Diseases at the University of Louisville and the healthcare epidemiologist at Norton Children’s Hospital. “This book offers practical guidance and solutions for the unique infection prevention challenges that providers encounter in pediatric settings on a daily basis.”

Developed by the Pediatric Infectious Diseases Society, the world’s largest organization focused on the treatment, control, and eradication of infectious diseases that affect children, the handbook addresses various infections and related issues across the spectrum of healthcare settings, from acute care hospitals and ambulatory practices to long-term care facilities. Covered topics include respiratory pathogens, surgical site infections, multidrug-resistant organisms, C. difficile, norovirus, device-associated infections, and antimicrobial stewardship, among many others.

Written by noted experts in the field, each chapter opens with a real-world clinical scenario, followed by frequently raised questions. Links to evidence-based guidelines are provided where available, in addition to expert guidance in areas where guidelines do not currently exist. Sample policies for institutions, algorithms, and educational tools are also included in the Handbook of Pediatric Infection Prevention and Control, which is published by Oxford University Press. The book’s co-editors also wish to offer their sincere thanks to the Pediatric Leadership Council steering committee of the Society for Healthcare Epidemiology of America (SHEA) for its many contributions. SHEA has helped define best practices in healthcare epidemiology and infection prevention worldwide since its founding in 1980.

“We hope this book fills an important need,” said handbook co-editor Judith A. Guzman-Cottrill, DO, professor of pediatrics in the Division of Infectious Diseases at Oregon Health & Science University. “We sought to create an essential resource for infection preventionists, healthcare epidemiologists, infectious disease fellows, and anyone who provides support for infection prevention programs in pediatric facilities.”

###

The Pediatric Infectious Diseases Society (PIDS) is the world’s largest professional organization of experts in the care and prevention of infectious diseases in children. PIDS membership includes leaders in clinical care, public health, academia, government, and industry who advocate for the improved health of children nationally and globally. The Society fulfills its mission through research, advocacy, guideline development, fellowship training, continuing medical education, its support of immunization practices in children, and the Journal of the Pediatric Infectious Diseases Society, its peer-reviewed publication, which recently received its first Impact Factor. To learn more about PIDS, visit www.pids.org and follow PIDS on Facebook and Twitter.